Where are you investing?

In an international strongly motivated group of highly qualified people with different experiences and skills relevant for the value creation within a biotech venture.

In a company with a proprietary flexible screening technology platform that can increase competitiveness of drug development process by cutting 70% of costs is early stages of discovery.

In a company focused in one of the most prevalent and fast growing therapeutic area – CNS.

In a company with programmes originated from its screening technology platform.

In a professionally structured company committed to create value to its shareholders.